Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Aicuris Anti-Infective Cures, Aivita Biomedical, Appili, Arca, Astellas, Astrazeneca, Atyr, Biontech, Biophytis, Calcimedica, Coherus, Cstone, Daiichi Sankyo, Edesa, Eiger, Eqrx, Gritstone, Hutchmed, Jemincare, Junshi, Pangu, Pfizer, Pharming, Providence, Redhill, Rottapharm, Sumitomo Dainippon, Takis, Urovant Sciences, Valneva, Vicore.